SEGMENT AND GEOGRAPHIC DATA

We segregate our operations into three reportable business segments: Orthopaedics, MedSurg, and Neurotechnology and Spine.

The Corporate and Other category shown in the table below includes corporate and administration, corporate initiatives and share-based compensation, which includes compensation related to employee stock options, restricted stock units and performance stock unit grants and director stock options and restricted stock unit grants.



Segment Results
	2018			2017			2016
Orthopaedics	$	4,991		$	4,713		$	4,422
MedSurg	$	6,045		5,557			4,894
Neurotechnology & Spine	2,565			2,174			2,009
Net sales	$	13,601		$	12,444		$	11,325
Orthopaedics	$	350		$	337		$	317
MedSurg	285			315			249
Neurotechnology & Spine	176			142			140
Segment depreciation and amortization	$	811		$	794		$	706
Corporate and Other	155			65			46
Total depreciation and amortization	$	966		$	859		$	752
Orthopaedics	$	1,804		$	1,681		$	1,602
MedSurg	1,444			1,228			1,087
Neurotechnology & Spine	700			631			559
Segment operating income	$	3,948		$	3,540		$	3,248
Items not allocated to segments:
Corporate and Other	$	(431	)	$	(402	)	$	(352	)
Acquisition & integration-related charges	(123		)	(64		)	(131		)
Amortization of intangible assets	(417		)	(371		)	(319		)
Restructuring related-charges	(220		)	(194		)	(125		)
Medical device regulations	(12		)	—			—
Recall-related matters	(23		)	(173		)	(158		)
Regulatory and legal matters	(185		)	(39		)	12
Consolidated operating income	$	2,537		$	2,297		$	2,175



Segment Assets and Capital Spending
Assets:	2018		2017		2016
Orthopaedics	$	8,873	$	7,486	$	7,048
MedSurg	10,417		9,759		8,553
Neurotechnology & Spine	7,260		4,105		4,129
Total segment assets	$	26,550	$	21,350	$	19,730
Corporate and Other	679		847		705
Total assets	$	27,229	$	22,197	$	20,435
Capital spending:
Orthopaedics	$	134	$	138	$	153
MedSurg	217		194		129
Neurotechnology & Spine	31		50		25
Total segment capital spending	$	382	$	382	$	307
Corporate and Other	190		216		183
Total capital spending	$	572	$	598	$	490

We measure the financial results of our reportable segments using an internal performance measure that excludes acquisition and integration-related charges, restructuring-related charges, reserves for certain product recall matters, reserves for certain legal and regulatory matters and a donation to an educational institution. Identifiable assets are those assets used exclusively in the operations of each business segment or allocated when used jointly. Corporate assets are principally cash and cash equivalents, marketable securities and property, plant and equipment.

The countries in which we have local revenue generating operations have been combined into the following geographic areas: the United States (including Puerto Rico); Europe, Middle East, Africa; Asia Pacific; and other foreign countries, which include Canada and countries in the Latin American region. Net sales are reported based off the geographic area of the Stryker location where the sales to the customer originated.



Geographic Information
	Net Sales						Net Property, Plant and Equipment
	2018		2017		2016		2018		2017
United States	$	9,848	$	9,059	$	8,230	$	1,348	$	1,102
Europe, Middle East, Africa	1,793		1,567		1,437		669		718
Asia Pacific	1,532		1,413		1,325		96		107
Other countries	428		405		333		178		48
Total	$	13,601	$	12,444	$	11,325	$	2,291	$	1,975